Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010360877> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2010360877 abstract "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CAmTOR inhibitor everolimus has been considered as a promising agent for breast cancer treatment especially among estrogen receptor (ER) positive postmenopausal advanced breast cancer. As expected, combination therapy of everolimus and steroidal aromatase inhibitor (AI) showed remarkable clinical efficacy for the first line nonsteroidal AI treatment failure patients in BOLERO-2 trial. However, the subsequent treatment after refractory to that therapy remains a great matter. We already reported several types of long term estrogen-depletion resistant (EDR) cell lines from MCF-7-E10, which has been constitutively ERE-GFP-transfected to monitor ER activity in living cells (Fujiki N et al., J Steroid Biochem Mol Biol. 2013 Oct 13;139C:61-72). They mimic AI resistance and these EDR cells have been characterized as the followings. 1) Type 1 as ER positive (ERE-GFP positive), constitutive ER overexpression without estrogen, and PI3K/Akt/mTOR pathway upregulated. 2) Type 2 as ER negative conversion (ERE-GFP negative) and IGF-1R/JNK signaling pathway upregulated. Then with those two types of sub-cell lines, we generated everolimus resistant cells after long term exposure to everolimus in estrogen depleted medium. Those everolimus resistant (EVR) cells are equivalent to resistance to the combination therapy of AI and everolimus as the second line endocrine treatment after the first line AI treatment failure. Though everolimus extremely inhibited cell proliferation of two EDR cell lines, everolimus resistant cells named as Type 1-EVR, Type 2-EVR no longer responded to everolimus. ER expression and estrogen sensitivity of two types of EVR cells were similar to those of the parental cells, respectively. Pure anti-estrogen fulvestrant inhibited cell proliferation of Type1-EVR cells. On the other hand, Type2-EVR did not respond to fulvestrant but JNK inhibitor inhibited the cell growth. Phosphorylation status of p70S6K and 4E-BP1 were different among individual parental EDR cells and EVR cells. Type1-EVR showed much higher expression of phosphorylation of MAP-kinase than the parental cells. In contrast, Type2-EVR expressed phosphorylation of MAP-kinase less than the parental cells. As above, the mechanism of acquired resistance to everolimus was likely to be different between those two sub-cell lines. This finding implies that different mechanisms of AI resistance follow different types of everolimus resistance.Citation Format: Mariko Kimura, Toru Hanamura, Toshifumi Niwa, Yuri Yamaguchi, Itaru Endo, Shin-ichi Hayashi. Molecular characterization of everolimus-resistant cell lines established from estrogen depletion-resistant MCF-7. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 2110. doi:10.1158/1538-7445.AM2014-2110" @default.
- W2010360877 created "2016-06-24" @default.
- W2010360877 creator A5003956323 @default.
- W2010360877 creator A5005950215 @default.
- W2010360877 creator A5027651565 @default.
- W2010360877 creator A5043460153 @default.
- W2010360877 creator A5051897132 @default.
- W2010360877 creator A5053254171 @default.
- W2010360877 date "2014-09-30" @default.
- W2010360877 modified "2023-09-25" @default.
- W2010360877 title "Abstract 2110: Molecular characterization of everolimus-resistant cell lines established from estrogen depletion-resistant MCF-7" @default.
- W2010360877 doi "https://doi.org/10.1158/1538-7445.am2014-2110" @default.
- W2010360877 hasPublicationYear "2014" @default.
- W2010360877 type Work @default.
- W2010360877 sameAs 2010360877 @default.
- W2010360877 citedByCount "0" @default.
- W2010360877 crossrefType "proceedings-article" @default.
- W2010360877 hasAuthorship W2010360877A5003956323 @default.
- W2010360877 hasAuthorship W2010360877A5005950215 @default.
- W2010360877 hasAuthorship W2010360877A5027651565 @default.
- W2010360877 hasAuthorship W2010360877A5043460153 @default.
- W2010360877 hasAuthorship W2010360877A5051897132 @default.
- W2010360877 hasAuthorship W2010360877A5053254171 @default.
- W2010360877 hasConcept C121608353 @default.
- W2010360877 hasConcept C126322002 @default.
- W2010360877 hasConcept C2776166826 @default.
- W2010360877 hasConcept C2778504769 @default.
- W2010360877 hasConcept C2779699572 @default.
- W2010360877 hasConcept C502942594 @default.
- W2010360877 hasConcept C530470458 @default.
- W2010360877 hasConcept C54355233 @default.
- W2010360877 hasConcept C62478195 @default.
- W2010360877 hasConcept C71924100 @default.
- W2010360877 hasConcept C75217442 @default.
- W2010360877 hasConcept C81885089 @default.
- W2010360877 hasConcept C84606932 @default.
- W2010360877 hasConcept C86554907 @default.
- W2010360877 hasConcept C86803240 @default.
- W2010360877 hasConcept C95444343 @default.
- W2010360877 hasConceptScore W2010360877C121608353 @default.
- W2010360877 hasConceptScore W2010360877C126322002 @default.
- W2010360877 hasConceptScore W2010360877C2776166826 @default.
- W2010360877 hasConceptScore W2010360877C2778504769 @default.
- W2010360877 hasConceptScore W2010360877C2779699572 @default.
- W2010360877 hasConceptScore W2010360877C502942594 @default.
- W2010360877 hasConceptScore W2010360877C530470458 @default.
- W2010360877 hasConceptScore W2010360877C54355233 @default.
- W2010360877 hasConceptScore W2010360877C62478195 @default.
- W2010360877 hasConceptScore W2010360877C71924100 @default.
- W2010360877 hasConceptScore W2010360877C75217442 @default.
- W2010360877 hasConceptScore W2010360877C81885089 @default.
- W2010360877 hasConceptScore W2010360877C84606932 @default.
- W2010360877 hasConceptScore W2010360877C86554907 @default.
- W2010360877 hasConceptScore W2010360877C86803240 @default.
- W2010360877 hasConceptScore W2010360877C95444343 @default.
- W2010360877 hasLocation W20103608771 @default.
- W2010360877 hasOpenAccess W2010360877 @default.
- W2010360877 hasPrimaryLocation W20103608771 @default.
- W2010360877 hasRelatedWork W1594602246 @default.
- W2010360877 hasRelatedWork W1975685996 @default.
- W2010360877 hasRelatedWork W1995900701 @default.
- W2010360877 hasRelatedWork W2018053964 @default.
- W2010360877 hasRelatedWork W2026629856 @default.
- W2010360877 hasRelatedWork W2030179432 @default.
- W2010360877 hasRelatedWork W2036061214 @default.
- W2010360877 hasRelatedWork W2130542734 @default.
- W2010360877 hasRelatedWork W2334005112 @default.
- W2010360877 hasRelatedWork W2399706222 @default.
- W2010360877 hasRelatedWork W2607157875 @default.
- W2010360877 hasRelatedWork W2789410779 @default.
- W2010360877 hasRelatedWork W2790011008 @default.
- W2010360877 hasRelatedWork W2793531790 @default.
- W2010360877 hasRelatedWork W2802055554 @default.
- W2010360877 hasRelatedWork W2887475383 @default.
- W2010360877 hasRelatedWork W3000633513 @default.
- W2010360877 hasRelatedWork W3013073823 @default.
- W2010360877 hasRelatedWork W3081702927 @default.
- W2010360877 hasRelatedWork W3181323486 @default.
- W2010360877 isParatext "false" @default.
- W2010360877 isRetracted "false" @default.
- W2010360877 magId "2010360877" @default.
- W2010360877 workType "article" @default.